Blood Urea Nitrogen, Creatinine and Proteinuria as Novel Biomarkers in Parkinson's Disease: Study Dr. Krishna Shah25 April 2024 6:00 AM ISTParkinson's disease (PD) is a progressive neurodegenerative disorder affecting movement and quality of life in the elderly. The causes of PD remain...
Jaslok Hospital unveils groundbreaking results in Parkinson's disease management Kajal Rajput14 April 2024 4:00 PM ISTMumbai: On the eve of World Parkinson's Day, Jaslok Hospital and Research Centre is proud to announce the unveiling of groundbreaking findings from...
Sun Pharma Advanced Research Company halts Parkinson's disease drug trial Ruchika Sharma10 April 2024 2:42 PM ISTMumbai: Sun Pharma Advanced Research Company Ltd. (SPARC) today announced results of interim analysis from the PROSEEK study, a global,...
People with essential tremor may have increased risk of dementia, reveals study Dr. Kamal Kant Kohli2 April 2024 9:00 PM ISTDementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general...
Continuous subcutaneous levodopa-carbidopa infusion safe, effective for treating Parkinson's disease: Lancet Dr. Kamal Kant Kohli19 March 2024 8:00 PM ISTUSA: An international, multisite phase 3 trial published in The Lancet Neurology journal showed the safety and effectiveness of Parkinson's disease...
Tandem cycling may improve health of those with Parkinson's and their care partners, states study Dr. Kamal Kant Kohli9 March 2024 3:00 AM ISTPedaling on a stationary bicycle built for two may improve the health and well-being for both people with Parkinson's disease and their care partners,...
AbbVie unveils Produodopa for Advanced Parkinson's Disease in EU Ruchika Sharma14 Jan 2024 1:00 PM ISTNorth Chicago, III.: AbbVie has announced the launch of PRODUODOPA (foslevodopa/foscarbidopa) in the European Union for the treatment of advanced...
Zydus Lifesciences gets USFDA nod to begin Phase II clinical trial of ZYIL1 in Parkinson's disease patients Ruchika Sharma18 Dec 2023 12:30 PM ISTZydus has been granted an 'Orphan Drug Designation' by the US FDA for ZYIL1 in treatment of patients with CAPS, a rare auto-inflammatory disease.
AbbVie to acquire Cerevel Therapeutics for USD 8.7 billion Ruchika Sharma8 Dec 2023 12:30 PM ISTNorth Chicago: AbbVie Inc. and Cerevel Therapeutics have announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its...
SPARC concludes enrolment in global Phase 2 study of Vodobatinib in early Parkinson's disease Ruchika Sharma30 Oct 2023 11:30 AM ISTVodobatinib is a potential first-in-class, highly selective and brain penetrating c-Abl inhibitor.
Tai Chi may curb Parkinson's disease symptoms and complications for several years Dr. Kamal Kant Kohli25 Oct 2023 10:30 AM ISTTai Chi, the Chinese martial art that involves sequences of very slow controlled movements, may curb the symptoms and complications of Parkinson's...
Loneliness Associated with Increased Risk of Developing Parkinson's disease Dr. Krishna Shah19 Oct 2023 11:00 AM ISTA large cohort study published in JAMA Neurology suggests that loneliness is associated with an increased risk of developing Parkinson's disease...
